Date: Jan 15, 2026
Category: Health & Technology
Oscar Murphy, diagnosed with an aggressive form of leukaemia, has become the first patient in the UK to receive pioneering CAR-T cell therapy through the NHS. The innovative treatment, which harnesses the power of the patient’s own immune cells to target and destroy cancer, marks a significant milestone in the fight against blood cancers. Describing his experience as 'very sci-fi', Oscar completed his CAR-T therapy and is now optimistic about his future. CAR-T therapy involves collecting a patient’s T-cells, genetically modifying them to recognize and attack cancer cells, and then infusing them back into the patient’s bloodstream. This personalized approach has shown remarkable results in clinical trials, especially for patients with aggressive or treatment-resistant leukaemia. Oscar’s journey highlights the NHS’s commitment to providing cutting-edge treatments and the hope that CAR-T therapy brings to patients and families facing blood cancer. As more patients gain access to this advanced therapy, experts believe it could transform the outlook for many living with leukaemia and other blood cancers. Read the source »
Share on:
Researchers have made a groundbreaking discovery, demonstrating how bacteria can trigger itch by stimulating nerve cells in the skin. This revelation holds potential for the development of innovative...
SonoBreasts, the sole clinic in Los Angeles with a SonoCine Automated Whole Breast Ultrasound, is dedicated to making breast health more accessible. Jasmine Khorsandi and SonoBreasts are leveraging...
Recent surveys indicate that consumers are optimistic about AI's potential to revolutionize healthcare, despite some reservations. As AI continues to make headlines, its role in transforming...
A groundbreaking AI model, trained on the life data of over a million individuals, has demonstrated the ability to predict an individual's lifespan with remarkable accuracy. This innovative...
A groundbreaking achievement in medical science, the world's first partial heart transplant has successfully grown valves and arteries after over a year of research. Duke Health's pioneering...
As the one-size-fits-all approach to healthcare evolves, the focus shifts to personalized medicine. This shift promises safer and more effective treatments tailored to individual needs, ultimately...